Coherus BioSciences Inc (NAS:CHRS)
$ 1.78 0.02 (1.14%) Market Cap: 204.21 Mil Enterprise Value: 423.31 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

Q2 2020 Coherus BioSciences Inc Earnings Call Transcript

Aug 06, 2020 / 08:30PM GMT
Release Date Price: $17.41 (-4.18%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Coherus Biosciences 2020 Second Quarter Earnings Conference Call. My name is Nora, and I'll be your conference operator for the call today. As a reminder, this conference call is being recorded.

I would now like to turn the call over to David Arrington, Coherus Investor Relations and Corporate Affairs. Please go ahead.

David S. Arrington
Coherus BioSciences, Inc. - VP of IR & Corporate Affairs

Thank you, Nora, and good afternoon, everyone. After close of market today, we issued a press release on our second quarter financial results. This release can be found on the Coherus Biosciences website. Joining me for today's call will be Denny Lanfear, Coherus' CEO; Dr. Jean Viret, Chief Financial Officer; Thomas Fitzpatrick, Chief Legal Officer; and Chris Thompson, Executive Vice President, Sales.

Before we begin our formal remarks, I would like to remind you that we will be making forward-looking statements, including risks and uncertainties related to the impact of COVID-19

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot